Skip to main content
. 2021 Mar 25;13(7):1508. doi: 10.3390/cancers13071508

Figure 3.

Figure 3

PSMA-PET/CT in MIP (A) of a 83-years old patient with prostate cancer (GS 8/group grade 4; PSA 32 ng/mL) and high intraprostatic SUVmax (49.63) and several metastases; Level of prostate (B) PSMA-PET Dx; (C) PSMA PET/CT Dx; Level of nodal metastases (D) PSMA-PET Dx; (E) PSMA PET/CT Dx.